TWD 21.15
(0.0%)
Year | Operating Income | Operating Income Growth |
---|---|---|
2023 | -19.33 Million TWD | -706.5% |
2022 | 2.12 Million TWD | 140.71% |
2021 | -5.21 Million TWD | -16932.26% |
2020 | 31 Thousand TWD | -99.55% |
2019 | 6.84 Million TWD | 0.0% |
Year | Operating Income | Operating Income Growth |
---|---|---|
2024 Q1 | -8.16 Million TWD | -78.06% |
2024 Q2 | -8.16 Million TWD | 0.0% |
2023 Q1 | -5.07 Million TWD | -512.12% |
2023 Q4 | -4.58 Million TWD | 0.0% |
2023 FY | -12.88 Million TWD | -706.5% |
2023 Q2 | -5.07 Million TWD | 0.0% |
2023 Q3 | -4.58 Million TWD | 9.64% |
2022 Q4 | -829.5 Thousand TWD | 0.0% |
2022 FY | 2.12 Million TWD | 140.71% |
2022 Q3 | -829.5 Thousand TWD | 0.0% |
2021 FY | -5.21 Million TWD | -16932.26% |
2020 FY | 31 Thousand TWD | -99.55% |
2019 FY | 6.84 Million TWD | 0.0% |
Name | Operating Income | Operating Income Difference |
---|---|---|
Allied Biotech Corporation | 88.71 Million TWD | 121.79% |
GeneFerm Biotechnology Co., Ltd. | 153.56 Million TWD | 112.588% |
Easywell Biomedicals, Inc. | -162.73 Million TWD | 88.121% |
TTY Biopharm Company Limited | 1.37 Billion TWD | 101.409% |
Synmosa Biopharma Corporation | 614.74 Million TWD | 103.145% |
Orient EuroPharma Co., Ltd. | 84.55 Million TWD | 122.862% |
Center Laboratories, Inc. | -79.26 Million TWD | 75.612% |
Tien Liang BioTech Co., Ltd. | 20.43 Million TWD | 194.593% |
Orient Pharma Co., Ltd. | 27.75 Million TWD | 169.654% |
InnoPharmax Inc. | -64.83 Million TWD | 70.186% |
Johnson Chemical Pharmaceutical Works Co., Ltd. | 105.57 Million TWD | 118.311% |
Excelsior Biopharma Inc. | -81.12 Million TWD | 76.172% |
DV Biomed Co., Ltd. | 173.54 Million TWD | 111.139% |
Foresee Pharmaceuticals Co., Ltd. | -1 Billion TWD | 98.082% |
Handa Pharmaceuticals, Inc. | 695.79 Million TWD | 102.778% |
UniPharma Co., Ltd. | -27.3 Million TWD | 29.203% |
Anxo Pharmaceutical Co., Ltd. | 53.15 Million TWD | 136.369% |
Alar Pharmaceuticals Inc. | 385.52 Million TWD | 105.014% |
Winston Medical Supply Co., Ltd. | 196.1 Million TWD | 109.858% |
Mercury Biopharmaceutical Corporation | -45.69 Million TWD | 57.691% |
TSH Biopharm Corporation Limited | 63.63 Million TWD | 130.38% |